Skip to content
About the Association
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Community Commitment
Careers
Contact Us
About the Association
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Community Commitment
Careers
Contact Us
Resources
2025 Savings Report
2025 Advocacy Priorities
2025 First Generics White Paper
Drug Shortages White Paper
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Blog
Founders Blogs
Amicus Briefs
Patient Stories
Resources
2025 Savings Report
2025 Advocacy Priorities
2025 First Generics White Paper
Drug Shortages White Paper
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Blog
Founders Blogs
Amicus Briefs
Patient Stories
Advocacy
Federal Advocacy
Biosimilars
GDUFA/BsUFA User Fees
Inflation Reduction Act
Intellectual Property & Patent Reform
Medicaid Generics Penalty
State Advocacy
Tariffs & Trade
Events
GRx+Biosims 2025
Access! 2026
Press Releases
JOIN
Advocacy
Federal Advocacy
Biosimilars
GDUFA/BsUFA User Fees
Inflation Reduction Act
Intellectual Property & Patent Reform
Medicaid Generics Penalty
State Advocacy
Tariffs & Trade
Events
GRx+Biosims 2025
Access! 2026
Press Releases
JOIN
SideMenu
Home
Press Releases
Biosimilars Council Press Releases
Press Releases
Press Releases
July 8, 2025
AAM
Groups Join the Biosimilars Council and AAM Letter of Support for Interchangeability Legislation
Press Releases
July 7, 2025
AAM
Mark Ratner Joins AAM to Lead Government Relations
Press Releases
June 30, 2025
AAM
Hikma Breaks Ground on Expanded U.S. Manufacturing and Announces $1 Billion Investment
Press Releases
June 12, 2025
AAM
Eighth Circuit Court Rules Unanimously for AAM in Generic Pricing Appeal
Press Releases
June 3, 2025
AAM
Generic and Biosimilar Patent Settlements Save $423 Billion
Press Releases
April 14, 2025
AAM
AAM Comments on Section 232 Investigation on Pharmaceuticals
Press Releases
April 14, 2025
AAM
AAM Commends Senate Q1/Q2 Bill Introduction
Press Releases
April 3, 2025
AAM
AAM Congratulates Dr. Oz on Confirmation as Administrator of the Centers for Medicare & Medicaid Services
Press Releases
April 1, 2025
AAM
AAM Comments on staff layoffs at FDA
Press Releases
March 27, 2025
AAM
AAM Congratulates FDA Commissioner Makary
Press Releases
March 7, 2025
AAM
AAM Commends Q1/Q2 House Bill Reintroduction
Press Releases
February 13, 2025
AAM
Association for Accessible Medicines on Confirmation of Robert F. Kennedy Jr. as Secretary of Health and Human Services
Load More
Resources
2025 Savings Report
2025 Advocacy Priorities
2025 First Generics White Paper
Drug Shortages White Paper
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Blog
Founders Blogs
Amicus Briefs
Patient Stories
About the Association
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Community Commitment
Careers
Contact Us
Advocacy
Federal Advocacy
Biosimilars
GDUFA/BsUFA User Fees
Inflation Reduction Act
Intellectual Property & Patent Reform
Medicaid Generics Penalty
State Advocacy
Tariffs & Trade
Events
GRx+Biosims 2025
Access! 2026
Press Releases
JOIN
About the Association
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Community Commitment
Careers
Contact Us
Resources
2025 Savings Report
2025 Advocacy Priorities
2025 First Generics White Paper
Drug Shortages White Paper
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Blog
Founders Blogs
Amicus Briefs
Patient Stories
Advocacy
Federal Advocacy
Biosimilars
GDUFA/BsUFA User Fees
Inflation Reduction Act
Intellectual Property & Patent Reform
Medicaid Generics Penalty
State Advocacy
Tariffs & Trade
Events
GRx+Biosims 2025
Access! 2026
Press Releases
JOIN